[Study of DNA fragmentation in target cells interacting with cytolytic T-lymphocytes]. 1994

N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015979 Killer Cells, Lymphokine-Activated Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are INTERLEUKIN-2-activated NK cells that have no MAJOR HISTOCOMPATIBILITY COMPLEX restriction or need for antigen stimulation. LAK cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients. LAK Cells,Lymphokine-Activated Killer Cells,Cell, LAK,Cell, Lymphokine-Activated Killer,Cells, LAK,Cells, Lymphokine-Activated Killer,Killer Cell, Lymphokine-Activated,Killer Cells, Lymphokine Activated,LAK Cell,Lymphokine Activated Killer Cells,Lymphokine-Activated Killer Cell
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
January 1988, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
November 1991, Cell,
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
August 1988, Journal of immunology (Baltimore, Md. : 1950),
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
October 1977, Biulleten' eksperimental'noi biologii i meditsiny,
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
May 1978, Biulleten' eksperimental'noi biologii i meditsiny,
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
January 1977, Annales d'immunologie,
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
January 1977, Doklady Akademii nauk SSSR,
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
September 1986, Journal of immunology (Baltimore, Md. : 1950),
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
June 1993, Experimental cell research,
N V Gnuchev, and L P Sashchenko, and O D Kabanova, and T I Luk'ianova, and E Iu Blishchenko, and S Iu Bykovskaia
January 1979, Cellular immunology,
Copied contents to your clipboard!